 Judith Blaine
Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 11 | 2025 | 63 | 6.240 |
Why?
| | Receptors, Fc | 8 | 2024 | 53 | 4.510 |
Why?
| | Histocompatibility Antigens Class I | 6 | 2023 | 202 | 2.890 |
Why?
| | Actin Cytoskeleton | 2 | 2020 | 101 | 1.250 |
Why?
| | Albumins | 4 | 2024 | 113 | 1.190 |
Why?
| | Serum Albumin | 3 | 2019 | 150 | 1.090 |
Why?
| | Immunoglobulin G | 5 | 2024 | 886 | 1.040 |
Why?
| | Phosphates | 6 | 2022 | 183 | 0.940 |
Why?
| | Kidney Tubules, Proximal | 5 | 2022 | 127 | 0.920 |
Why?
| | Kidney Diseases | 3 | 2023 | 406 | 0.910 |
Why?
| | Endocytosis | 3 | 2014 | 170 | 0.880 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 4 | 2022 | 9 | 0.810 |
Why?
| | Parathyroid Hormone | 4 | 2022 | 108 | 0.780 |
Why?
| | Lysosomes | 4 | 2023 | 142 | 0.760 |
Why?
| | Membrane Proteins | 3 | 2025 | 1163 | 0.720 |
Why?
| | Sodium-Phosphate Cotransporter Proteins | 5 | 2011 | 10 | 0.710 |
Why?
| | Glomerulonephritis | 1 | 2020 | 47 | 0.680 |
Why?
| | Kidney | 8 | 2023 | 1467 | 0.620 |
Why?
| | Animals | 29 | 2025 | 36862 | 0.580 |
Why?
| | MicroRNAs | 1 | 2025 | 699 | 0.580 |
Why?
| | Mice | 18 | 2025 | 17774 | 0.560 |
Why?
| | Fluorescein-5-isothiocyanate | 2 | 2014 | 35 | 0.550 |
Why?
| | Potassium Channels, Voltage-Gated | 3 | 2004 | 50 | 0.540 |
Why?
| | Mice, Knockout | 6 | 2023 | 3009 | 0.540 |
Why?
| | Interleukin-6 | 2 | 2019 | 778 | 0.500 |
Why?
| | Actins | 3 | 2020 | 416 | 0.490 |
Why?
| | Cells, Cultured | 8 | 2020 | 4197 | 0.470 |
Why?
| | Albuminuria | 2 | 2013 | 185 | 0.450 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIc | 2 | 2011 | 3 | 0.440 |
Why?
| | Caveolae | 1 | 2014 | 17 | 0.440 |
Why?
| | Protein Transport | 5 | 2021 | 444 | 0.440 |
Why?
| | Magnesium | 1 | 2014 | 158 | 0.440 |
Why?
| | Proteolysis | 3 | 2025 | 178 | 0.430 |
Why?
| | Kidney Glomerulus | 3 | 2019 | 114 | 0.400 |
Why?
| | Proteinuria | 3 | 2021 | 97 | 0.380 |
Why?
| | Myosin Heavy Chains | 2 | 2011 | 191 | 0.370 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 109 | 0.340 |
Why?
| | Signal Transduction | 4 | 2021 | 5078 | 0.340 |
Why?
| | Potassium Channels | 2 | 2001 | 150 | 0.310 |
Why?
| | Calcium | 2 | 2014 | 1198 | 0.300 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 294 | 0.300 |
Why?
| | Transcytosis | 2 | 2021 | 7 | 0.290 |
Why?
| | Cell Membrane | 4 | 2009 | 737 | 0.290 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 5753 | 0.280 |
Why?
| | Phosphorus, Dietary | 3 | 2011 | 4 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2012 | 612 | 0.240 |
Why?
| | Cathepsin D | 1 | 2025 | 18 | 0.240 |
Why?
| | Cell Line | 4 | 2021 | 2841 | 0.230 |
Why?
| | Apoptosis | 1 | 2013 | 2554 | 0.210 |
Why?
| | Microvilli | 4 | 2011 | 78 | 0.210 |
Why?
| | Antigen-Antibody Complex | 1 | 2023 | 90 | 0.200 |
Why?
| | Endosomes | 1 | 2024 | 136 | 0.200 |
Why?
| | Rats | 4 | 2024 | 5639 | 0.200 |
Why?
| | Protein Isoforms | 1 | 2024 | 403 | 0.190 |
Why?
| | Humans | 19 | 2025 | 137294 | 0.190 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 15 | 0.190 |
Why?
| | Complement Factor H | 1 | 2022 | 75 | 0.180 |
Why?
| | Inflammation | 1 | 2013 | 2836 | 0.180 |
Why?
| | Sodium-Hydrogen Exchangers | 2 | 2011 | 24 | 0.180 |
Why?
| | Glomerular Basement Membrane | 1 | 2020 | 8 | 0.180 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.170 |
Why?
| | Opossums | 2 | 2011 | 9 | 0.170 |
Why?
| | Vascular Calcification | 1 | 2022 | 108 | 0.170 |
Why?
| | Homeostasis | 3 | 2014 | 619 | 0.170 |
Why?
| | Glomerular Filtration Rate | 2 | 2014 | 745 | 0.170 |
Why?
| | Microscopy, Fluorescence | 3 | 2011 | 397 | 0.170 |
Why?
| | Focal Adhesions | 1 | 2020 | 44 | 0.170 |
Why?
| | Disease Models, Animal | 4 | 2021 | 4284 | 0.170 |
Why?
| | Nephrectomy | 1 | 2021 | 168 | 0.160 |
Why?
| | Flow Cytometry | 2 | 2020 | 1184 | 0.160 |
Why?
| | Lipocalins | 1 | 2019 | 36 | 0.160 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2113 | 0.160 |
Why?
| | Disease | 1 | 2020 | 98 | 0.160 |
Why?
| | Autoimmune Diseases | 1 | 2023 | 460 | 0.160 |
Why?
| | Cell Line, Transformed | 1 | 2019 | 145 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2004 | 858 | 0.160 |
Why?
| | Allografts | 1 | 2019 | 146 | 0.150 |
Why?
| | Cytoskeleton | 2 | 2011 | 188 | 0.150 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 181 | 0.150 |
Why?
| | Phosphoproteins | 2 | 2011 | 338 | 0.150 |
Why?
| | Ion Channel Gating | 1 | 1998 | 89 | 0.150 |
Why?
| | Autophagy | 1 | 2021 | 281 | 0.150 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2019 | 368 | 0.140 |
Why?
| | Neurons | 2 | 2004 | 1588 | 0.140 |
Why?
| | Shab Potassium Channels | 3 | 2004 | 18 | 0.140 |
Why?
| | Xenopus | 3 | 2004 | 87 | 0.140 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2014 | 38 | 0.130 |
Why?
| | Fibroblast Growth Factors | 2 | 2022 | 171 | 0.120 |
Why?
| | Cell Polarity | 2 | 2014 | 141 | 0.120 |
Why?
| | Inflammation Mediators | 2 | 2021 | 514 | 0.120 |
Why?
| | Renal Reabsorption | 1 | 2014 | 4 | 0.120 |
Why?
| | Gastrointestinal Absorption | 1 | 2014 | 5 | 0.120 |
Why?
| | Renal Elimination | 1 | 2014 | 6 | 0.120 |
Why?
| | Losartan | 1 | 2014 | 14 | 0.110 |
Why?
| | Lisinopril | 1 | 2014 | 13 | 0.110 |
Why?
| | Denys-Drash Syndrome | 1 | 2014 | 4 | 0.110 |
Why?
| | WT1 Proteins | 1 | 2014 | 15 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2021 | 1095 | 0.110 |
Why?
| | Microscopy, Confocal | 2 | 2019 | 324 | 0.110 |
Why?
| | Endothelial Cells | 1 | 2019 | 779 | 0.110 |
Why?
| | Biomarkers | 3 | 2019 | 4164 | 0.110 |
Why?
| | Metabolic Diseases | 1 | 2014 | 108 | 0.100 |
Why?
| | Ion Transport | 2 | 2011 | 60 | 0.100 |
Why?
| | Mutation | 3 | 2020 | 3956 | 0.100 |
Why?
| | Protease Inhibitors | 1 | 2014 | 106 | 0.100 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 201 | 0.100 |
Why?
| | Vesicular Transport Proteins | 1 | 2014 | 84 | 0.100 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 2 | 2009 | 5 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 3 | 2014 | 2486 | 0.100 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2011 | 177 | 0.100 |
Why?
| | Caspases | 1 | 2013 | 247 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 811 | 0.090 |
Why?
| | Orphan Nuclear Receptors | 1 | 2011 | 15 | 0.090 |
Why?
| | Green Fluorescent Proteins | 2 | 2004 | 390 | 0.090 |
Why?
| | Absorption | 1 | 2011 | 63 | 0.090 |
Why?
| | Biological Transport, Active | 1 | 2011 | 77 | 0.090 |
Why?
| | Membrane Potentials | 2 | 2004 | 283 | 0.090 |
Why?
| | Repressor Proteins | 1 | 2014 | 427 | 0.090 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 168 | 0.080 |
Why?
| | Kinetics | 1 | 2014 | 1674 | 0.080 |
Why?
| | Hormones | 1 | 2011 | 142 | 0.080 |
Why?
| | Delayed Rectifier Potassium Channels | 2 | 2001 | 9 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2004 | 664 | 0.080 |
Why?
| | Cytokines | 2 | 2021 | 2090 | 0.080 |
Why?
| | Genes, Dominant | 1 | 2009 | 95 | 0.080 |
Why?
| | Potassium Deficiency | 1 | 2009 | 1 | 0.080 |
Why?
| | NF-kappa B | 1 | 2013 | 691 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2164 | 0.080 |
Why?
| | Aging | 1 | 2019 | 1864 | 0.070 |
Why?
| | Intestine, Small | 1 | 2009 | 156 | 0.070 |
Why?
| | Dopamine | 1 | 2011 | 303 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2011 | 455 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2009 | 2839 | 0.070 |
Why?
| | Hypophosphatemia, Familial | 1 | 2006 | 4 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 2608 | 0.060 |
Why?
| | Sodium-Bicarbonate Symporters | 1 | 2005 | 2 | 0.060 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2005 | 150 | 0.060 |
Why?
| | Angiotensin II | 1 | 2005 | 99 | 0.060 |
Why?
| | Gene Expression | 2 | 2001 | 1501 | 0.060 |
Why?
| | Male | 5 | 2021 | 67560 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2005 | 261 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 867 | 0.050 |
Why?
| | Spinal Cord | 1 | 2004 | 370 | 0.050 |
Why?
| | Kv1.1 Potassium Channel | 1 | 2001 | 8 | 0.040 |
Why?
| | Microinjections | 1 | 2001 | 86 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2021 | 62 | 0.040 |
Why?
| | Embryo, Nonmammalian | 1 | 2001 | 167 | 0.040 |
Why?
| | Female | 3 | 2021 | 73052 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 125 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 171 | 0.040 |
Why?
| | Patch-Clamp Techniques | 1 | 2001 | 286 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2001 | 178 | 0.040 |
Why?
| | Acute-Phase Proteins | 1 | 2019 | 67 | 0.040 |
Why?
| | Lipocalin-2 | 1 | 2019 | 79 | 0.040 |
Why?
| | Isoantibodies | 1 | 2019 | 60 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2022 | 327 | 0.040 |
Why?
| | Complement Activation | 1 | 2022 | 411 | 0.040 |
Why?
| | Biological Transport | 2 | 2011 | 417 | 0.040 |
Why?
| | Models, Neurological | 1 | 2001 | 243 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2019 | 216 | 0.040 |
Why?
| | Hepatocytes | 1 | 2019 | 220 | 0.040 |
Why?
| | Electrophysiology | 1 | 1998 | 217 | 0.040 |
Why?
| | Risk Factors | 1 | 2012 | 10368 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1998 | 376 | 0.040 |
Why?
| | Action Potentials | 1 | 2001 | 495 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 844 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 679 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 1998 | 2147 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 1998 | 2904 | 0.030 |
Why?
| | Creatinine | 1 | 2014 | 499 | 0.020 |
Why?
| | Liver X Receptors | 1 | 2011 | 31 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1063 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 177 | 0.020 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2009 | 9 | 0.020 |
Why?
| | Enterocytes | 1 | 2009 | 16 | 0.020 |
Why?
| | Cytoplasmic Vesicles | 1 | 2009 | 14 | 0.020 |
Why?
| | Jejunum | 1 | 2009 | 31 | 0.020 |
Why?
| | Hypophosphatemia | 1 | 2009 | 17 | 0.020 |
Why?
| | Duodenum | 1 | 2009 | 77 | 0.020 |
Why?
| | Ligands | 1 | 2011 | 664 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 549 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1226 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2011 | 622 | 0.020 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2005 | 25 | 0.020 |
Why?
| | Xenopus laevis | 1 | 2005 | 106 | 0.010 |
Why?
| | Protein Binding | 1 | 2011 | 2225 | 0.010 |
Why?
| | Oocytes | 1 | 2005 | 180 | 0.010 |
Why?
| | Transfection | 1 | 2005 | 947 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1773 | 0.010 |
Why?
|
|
Blaine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|